Chin J Schisto Control ›› 2018, Vol. 30 ›› Issue (4): 465-471.

Previous Articles     Next Articles

Progress in researches on molecular markers of non-Plasmodium falciparum drug resistance

CHEN Jing| ZHANG Mei-hua| TANG Jian-xia| LIU Yao-bao| CAO Jun*   

  1. Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention| Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology| WHO Collaborating Centre for Research and Training on Malaria Elimination| Jiangsu Institute of Parasitic Diseases| Wuxi 214064| China
  • Online:2018-10-08 Published:2018-10-09
  • Contact: CAO Jun

非恶性疟人体疟原虫药物抗性分子标记研究进展

陈静|张梅花|唐建霞|刘耀宝|曹俊*   

  1. 国家卫生健康委员会寄生虫病预防与控制技术重点实验室、江苏省寄生虫与媒介控制技术重点实验室、世界卫生组织消除疟疾研究与培训合作中心、江苏省寄生虫病防治研究所(无锡 214064)
  • 通讯作者: 曹俊
  • 作者简介:陈静|女|硕士研究生。研究方向:病原生物学
  • 基金资助:
    国家重点研发计划(2016YFC1200500);江苏省自然科学基金杰出青年基金(BK20150001);江苏省重点研发计划(社会发展) (BE2016631)

Abstract: With the long?term and widespread application of antimalarial drugs, Plasmodium falciparum has gradually produced resistance to antimalarial drugs. At present, there are more researches on the molecular markers of P. falciparum drug resistance, while less attention has been paid to the molecular markers of non?P. falciparum drug resistance. In order to provide the reference for rational drug use in clinical treatment and reference for molecular monitoring of antimalarial drug sensitivity of non?P. falciparum, this paper reviews the researches on the common molecular markers related to non?P. falciparum drug resistance.

Key words: Non?Plasmodium falciparum; Drug resistance; Molecular marker

摘要: 随着抗疟药的长期、广泛使用,疟原虫对抗疟药逐渐产生抗性。目前有关恶性疟原虫的抗药性分子标记研究较多,而对非恶性疟原虫关注度相对较小。为了更好地为临床治疗的合理用药提供科学依据,为非恶性疟人体疟原虫对抗疟药敏感性分子监测提供参考,本文就非恶性疟人体疟原虫常见抗药性相关分子标记的研究进展作一综述。

关键词: 非恶性疟原虫;抗药性;分子标记

CLC Number: